These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29930294)

  • 21. Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes.
    Webb MW; Sun J; Sheard MA; Liu WY; Wu HW; Jackson JR; Malvar J; Sposto R; Daniel D; Seeger RC
    Int J Cancer; 2018 Sep; 143(6):1483-1493. PubMed ID: 29665011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
    Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
    Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CSF-I and CSF-I receptor by normal lactating mammary epithelial cells.
    Sapi E; Flick MB; Rodov S; Carter D; Kacinski BM
    J Soc Gynecol Investig; 1998; 5(2):94-101. PubMed ID: 9509388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.
    Quail DF; Bowman RL; Akkari L; Quick ML; Schuhmacher AJ; Huse JT; Holland EC; Sutton JC; Joyce JA
    Science; 2016 May; 352(6288):aad3018. PubMed ID: 27199435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.
    Klopp AH; Lacerda L; Gupta A; Debeb BG; Solley T; Li L; Spaeth E; Xu W; Zhang X; Lewis MT; Reuben JM; Krishnamurthy S; Ferrari M; Gaspar R; Buchholz TA; Cristofanilli M; Marini F; Andreeff M; Woodward WA
    PLoS One; 2010 Aug; 5(8):e12180. PubMed ID: 20808935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
    Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
    Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
    Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
    Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel role for PDEF in epithelial cell migration and invasion.
    Gunawardane RN; Sgroi DC; Wrobel CN; Koh E; Daley GQ; Brugge JS
    Cancer Res; 2005 Dec; 65(24):11572-80. PubMed ID: 16357167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
    Wolfe AR; Trenton NJ; Debeb BG; Larson R; Ruffell B; Chu K; Hittelman W; Diehl M; Reuben JM; Ueno NT; Woodward WA
    Oncotarget; 2016 Dec; 7(50):82482-82492. PubMed ID: 27756885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent E-cadherin expression in inflammatory breast cancer.
    Kleer CG; van Golen KL; Braun T; Merajver SD
    Mod Pathol; 2001 May; 14(5):458-64. PubMed ID: 11353057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
    Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
    J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
    Lee AW; Nambirajan S; Moffat JG
    Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
    Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
    Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells.
    Cohen EN; Gao H; Anfossi S; Mego M; Reddy NG; Debeb B; Giordano A; Tin S; Wu Q; Garza RJ; Cristofanilli M; Mani SA; Croix DA; Ueno NT; Woodward WA; Luthra R; Krishnamurthy S; Reuben JM
    PLoS One; 2015; 10(7):e0132710. PubMed ID: 26207636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
    Shah P; Gau Y; Sabnis G
    Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor.
    Sapi E; Flick MB; Rodov S; Gilmore-Hebert M; Kelley M; Rockwell S; Kacinski BM
    Cancer Res; 1996 Dec; 56(24):5704-12. PubMed ID: 8971179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.